The present study suggests that the beneficial effects of quetiapine on schizophrenia might be related to its neuroprotective effect on brain myelin basic protein and its upregulating neuroprotective proteins such as BDNF, and indicate that modulation of cerebral demyelination could be a novel treatment target of schizophrenia. The gene discussed is BDNF; the disease is schizophrenia.